Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
OPINION
Visa Insider Buys $400K Worth
By Jonathan Moreland
May 6, 2009 9:48 AM EDT
OPINION
Heartland Payment Chairman Sells Stock
By Jonathan Moreland
Apr 22, 2009 10:02 AM EDT
OPINION
JPMorgan Insider Sells $1.2M Worth
By Jonathan Moreland
Apr 20, 2009 9:30 AM EDT
OPINION
Shutterfly Insider Sells $580,000 Worth
By Jonathan Moreland
Apr 9, 2009 9:28 AM EDT
STOCKS
Biotech Stock Mailbag: Fans Rally 'Round Arena
By Adam Feuerstein
Mar 27, 2009 7:59 AM EDT
STOCKS
Cell Genesys' Net Loss Reduces
By TheStreet Ratings
Mar 10, 2009 1:11 PM EDT
STOCKS
Biotech Scorecard: My Best and Worst Calls
By Adam Feuerstein
Jan 2, 2009 6:59 AM EST
STOCKS
Biotech Mailbag 2008 Review
By Adam Feuerstein
Dec 29, 2008 12:20 PM EST
STOCKS
Elan's Martin Named Worst Biotech CEO of '08
By Adam Feuerstein
Dec 11, 2008 10:44 AM EST
INVESTING
Biotech Stock-Picking: Incyte, Celgene
By TSC Staff
Oct 27, 2008 6:37 PM EDT
STOCKS
Biotech Mailbag: Lessons From Clinical Trials
By Adam Feuerstein
Oct 24, 2008 4:10 PM EDT
INVESTING
Health Winners & Losers: Gilead
By Elizabeth Trotta
Oct 16, 2008 3:31 PM EDT
STOCKS
Cell Genesys Halts Second GVAX Trial
By Elizabeth Trotta
Oct 16, 2008 12:50 PM EDT
STOCKS
Biotech Mailbag: Avoid Nuvelo-ARCA Merger
By Adam Feuerstein
Sep 26, 2008 11:05 AM EDT
STOCKS
Biotech Mailbag: Epix Pharmaceuticals
By Adam Feuerstein
Sep 5, 2008 6:59 AM EDT
INVESTING
Three Biotech Stocks That Could Double
By James Altucher
Sep 2, 2008 1:54 PM EDT
INVESTING
Health Winners & Losers: Amylin
By Elizabeth Trotta
Aug 28, 2008 4:33 PM EDT
INVESTING
Health Winners & Losers: Cell Genesys
By Elizabeth Trotta
Aug 27, 2008 4:55 PM EDT
STOCKS
Cell Genesys Ends Prostate Cancer Study
By Elizabeth Trotta
Aug 27, 2008 10:52 AM EDT
STOCKS
Biotech-Stock Mailbag: Amylin
By Adam Feuerstein
Aug 22, 2008 1:20 PM EDT
STOCKS
Feuerstein's Biotech-Stock Mailbag
By Adam Feuerstein
May 30, 2008 10:36 AM EDT
STOCKS
Cell Genesys Issues Stock in Private Placement
By Elizabeth Trotta
May 12, 2008 10:50 AM EDT
STOCKS
Japan's Takeda Will Pay $9B for Millennium
By Adam Feuerstein
Apr 10, 2008 7:05 AM EDT
INVESTING
Tuesday's Winners & Losers: Cell Genesys
By TSC Staff
Apr 1, 2008 4:32 PM EDT
INVESTING
Tuesday's Health Winners & Losers
By Elizabeth Trotta
Apr 1, 2008 4:08 PM EDT
